Nuo Therapeutics, Inc. (AURX) Financial Statements (2024 and earlier)

Company Profile

Business Address 8285 EL RIO, SUITE 150
HOUSTON, TX 77054
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,0511,4156376942,620922
Cash and cash equivalents2,0511,4156376942,620922
Restricted cash and investments55   5453
Receivables92 221142941,014
Inventory, net of allowances, customer advances and progress billings240 253670254
Inventory240 253670254
Prepaid expense      225
Other undisclosed current assets19651182342334579
Total current assets:2,6351,4668671,1853,3723,049
Noncurrent Assets
Operating lease, right-of-use asset359 
Property, plant and equipment53 1052244861,115
Intangible assets, net (including goodwill)     9,9202,513
Goodwill     2,079 
Intangible assets, net (excluding goodwill)     7,8402,513
Other noncurrent assets   315279396
Total noncurrent assets:412 10923910,6854,025
TOTAL ASSETS:3,0471,4669751,42414,0577,074
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5216737359371,4476,663
Interest and dividends payable 12  3,143
Accounts payable3985274373803931,067
Accrued liabilities1231472855571,0552,453
Debt   309  35,000
Derivative instruments and hedges, liabilities   14   
Deferred revenue and credits  524
Other undisclosed current liabilities79     
Total current liabilities:6006731,0579371,44742,187
Noncurrent Liabilities
Liabilities, other than long-term debt256  4123944
Deferred revenue and credits  637
Other liabilities    4123307
Operating lease, liability256 
Other undisclosed noncurrent liabilities (0)     
Total noncurrent liabilities:256  4123944
Total liabilities:8566731,0579411,57143,132
Temporary equity, carrying amount      500
Equity
Equity, attributable to parent, including:2,191793(82)48312,486(36,558)
Preferred stock   000 
Common stock4422112
Additional paid in capital28,95224,38222,13221,15518,181125,957
Accumulated deficit(26,765)(23,593)(22,217)(20,675)(5,696)(162,920)
Other undisclosed equity, attributable to parent      393
Total equity:2,191793(82)48312,486(36,558)
TOTAL LIABILITIES AND EQUITY:3,0471,4669751,42414,0577,074

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues112 1,371721 11,511
Revenue, net721 11,511
Cost of revenue
(Cost of Goods and Services Sold)
(19) (163)(1,091) (7,967)
Gross profit:93 1,208(370) 3,544
Operating expenses(3,414)(91)(2,712)(15,164) (44,863)
Other undisclosed operating income      
Operating loss:(3,321)(91)(1,505)(15,534) (41,319)
Nonoperating income (expense)5 (37)555 (11,578)
Investment income, nonoperating      29,847
Other nonoperating income (expense) 5 2566 (11)
Interest and debt expense   (39)(11) (39,313)
Loss from continuing operations before equity method investments, income taxes:(3,316)(91)(1,581)(14,990) (92,210)
Other undisclosed income from continuing operations before income taxes144 3911 39,313
Loss from continuing operations before income taxes:(3,172)(91)(1,542)(14,979) (52,897)
Income tax expense (benefit)   (405)13,588 89
Loss from continuing operations:(3,172)(91)(1,947)(1,391) (52,808)
Loss before gain (loss) on sale of properties:(91)(1,947)(1,391) (52,808)
Net loss:(3,172)(91)(1,947)(1,391) (52,808)
Other undisclosed net income (loss) attributable to parent  405(13,588)  
Net loss attributable to parent:(3,172)(91)(1,542)(14,979) (52,808)
Preferred stock dividends and other adjustments  (796)    
Net loss available to common stockholders, diluted:(3,172)(886)(1,542)(14,979) (52,808)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(3,172)(91)(1,947)(1,391) (52,808)
Comprehensive loss, net of tax, attributable to parent:(3,172)(91)(1,947)(1,391) (52,808)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: